JULIA MAYOTTE: Open Payments
NPI 1710744347 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$270 in 7 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $598 · 2025 $270
Food & beverage: $270
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $162 |
| Incyte Corporation | 2 | $54 |
| Janssen Scientific Affairs, LLC | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: RYBREVANT, ZYNYZ, KEYTRUDA.
Industry payments across DC — which companies pay providers there.
